Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
7,341 total articles
Thomas J. Herzfeld, chairman of the advisor to Herzfeld Credit Income Fund, Inc. (HERZ), acquired 3,610 shares of the closed-end fund on April 15, 2026, at $16.0141 per share for a total of $57,810. The transaction leaves Herzfeld with 197,248 shares. The fund currently trades at $16.69, is down 25% year-to-date, carries an 82% dividend yield, and …
Rakuten Group, Inc., Rakuten Mobile, Inc. and founder Mikitani Hiroshi sold a combined 3,040,000 shares of AST SpaceMobile Class A common stock on April 14-15, 2026, generating roughly $270 million in proceeds. The transactions were executed in two tranches with differing weighted average prices. The sales follow a 289% share-price rise over the pa…
Patrick P. Gelsinger, a director at Gloo Holdings, purchased 36,653 shares of Class A common stock on April 16, 2026, for a total of $264,634 in multiple transactions. The insider buying occurred as GLOO shares rose sharply over the prior week, while broader indicators show mixed company fundamentals including revenue outperformance and an earnings…
Gloo Holdings President and CEO Scott Arthur Beck purchased 27,386 shares of Class A Common Stock on April 16, 2026, spending about $198,000 at a weighted average price of $7.23. The transaction increases his indirect holdings in Class A shares to 439,886. The purchase coincides with a recent 43% weekly surge in the stock and follows a fiscal year …
HeartBeam director Richard Ferrari purchased 62,500 shares of common stock at $0.80 per share on April 16, 2026, representing a $50,000 acquisition tied to the company's underwritten public offering. The transaction increases his direct holdings to 291,636 shares. The stock traded near $0.81, close to its 52-week low, after a 30% slide over the pri…
HeartBeam President Eno Robert Paul purchased 12,500 shares of common stock on April 16, 2026, paying $0.80 per share for a $10,000 transaction. The purchase occurred as the stock traded near $0.81 following a steep weekly drop. The transaction coincides with HeartBeam's recent $10 million gross proceeds offering and the start of analyst coverage f…
HeartBeam director Marga Ortigas-Wedekind purchased 25,000 common shares on April 16, 2026, at $0.80 per share, a $20,000 transaction that brings her direct holdings to 137,293 shares. The buy was made in connection with HeartBeam’s underwritten public offering of 12,500,000 shares, which priced April 14, 2026 and closed April 16, 2026. The stock t…
HeartBeam director Mark E. Strome purchased 750,000 shares of common stock at $0.80 per share on April 16, 2026, a transaction valued at $600,000. The acquisition was executed in connection with the companys underwritten public offering of 12,500,000 shares. Following the buy, Strome's direct and indirect holdings total 3,650,000 shares. The stock…
Michael R. Jaff, a director of HeartBeam, reported buying 31,250 shares of the company's common stock on April 16, 2026, for $0.80 per share, totaling $25,000. The transaction was connected to HeartBeam's underwritten public offering of 12.5 million shares, which priced April 14 and closed April 16. HeartBeam also confirmed a $10 million sale of co…
HeartBeam, Inc. (NASDAQ: BEAT) Chief Financial Officer Tim Cruickshank purchased 31,250 shares on April 16, 2026, paying $0.80 per share for a total of $25,000, according to an SEC Form 4 filing. The transaction coincided with the closing of an underwritten public offering that raised $10 million. The stock is trading near its 52-week low and has f…
HeartBeam director Branislav Vajdic bought 31,250 shares of the company on April 16, 2026 at $0.80 per share, a $25,000 investment that raises his direct holdings to 909,914 shares. The transaction coincides with HeartBeam's $10 million public offering of 12.5 million shares priced at $0.80 and new Buy-coverage from B. Riley and D. Boral Capital.
HeartBeam director Willem Elfrink acquired 187,500 common shares on April 16, 2026, spending $150,000 at $0.80 per share. The purchase — tied to an underwritten public offering — raises his direct holdings to 538,667 shares. The transaction follows a 30% weekly decline in the stock, which is trading near $0.81.
Saira Ramasastry, a director at Mirum Pharmaceuticals, sold 2,000 shares of common stock on April 15, 2026, for $193,800 and simultaneously exercised 2,000 options. The transaction occurred under a Rule 10b5-1 trading plan established in September 2025 as the company faces multiple analyst updates and key clinical readouts scheduled for 2026.
Liquidia Corp Chief Executive Officer Roger Jeffs sold 53,300 shares of company common stock from April 14 to April 16, 2026, in transactions that totaled $2.14 million. The sales were carried out under a Rule 10b5-1 trading plan adopted November 5, 2025. The company recently reported a mixed fourth-quarter 2025 result, led by strong revenue from i…
Sandeep Bharathi, president of Marvell Technology's Data Center Group, sold 66,892 shares on April 16, 2026, generating roughly $8.7 million. The transaction occurred while the stock traded close to a 52-week peak and after a year of substantial share gains. Concurrent option exercises and share surrenders to cover taxes were also reported. Separat…
Liquidia Corp Chief Financial Officer and Chief Operating Officer Michael Kaseta reported the exercise of incentive stock options and the sale of common shares on April 14 and 15, 2026. The transactions, disclosed in an SEC Form 4 filing, comprised the exercise of 89,971 options and the sale of 139,390 common shares at prices between $40.00 and $40…
Bryan Ganz, former President, CEO and Director of Byrna Technologies Inc (NASDAQ:BYRN), purchased 1,500 shares of the company’s common stock on April 15, 2026, in a series of transactions totaling $9,840. The trade raises his direct holdings to 382,673 shares. The disclosure comes after Byrna reported first-quarter 2026 results that missed analyst …
AIPCT Holdings LLC and affiliated entities sold 3,041,288 shares of Titan International Inc. (TWI) common stock on March 4, 2026, at $8.95 per share, bringing proceeds of $27,219,527. The combined holding for the reporting entities is now 8,880,478 shares. Titan's stock has since fallen to $7.73. Separately, Titan reported fourth-quarter 2025 reven…
Director Jack Bendheim and a 10% holder, BFI Co., LLC, sold a combined $1,201,595 of Phibro Animal Health Corp. (PAHC) stock across multiple trades from April 14 to April 16, 2026. The disposals occurred as the share price traded near its 52-week high, and coincided with a reporting period in which the company reported fiscal Q2 results that outper…
Marc A. Nemati, President and Chief Executive Officer of GrabAGun Digital Holdings Inc (PEW), sold 4,083 shares on April 16, 2026, to satisfy tax withholding tied to vested restricted stock units. The sale - executed under a pre-arranged Rule 10b5-1 plan and disclosed on a Form 4 - occurred as the stock trades close to its 52-week low. The prior da…
GrabAGun Digital Holdings Inc. Chief Financial Officer Justin C. Hilty sold 2,043 shares on April 16, 2026, at $2.98 per share to satisfy tax withholding tied to the conversion and vesting of restricted stock units. The move followed the one-for-one conversion of 8,334 restricted stock units on April 15, 2026, executed under a pre-arranged Rule 10b…
Adam Crystal, President of R&D at Tango Therapeutics (TNGX), reported a sale of 38,460 shares at $25.00 per share, netting $961,500, pursuant to a Form 4 filed with the SEC. The sale followed an exercise of options to acquire the same number of shares at $5.20 each. Tango has also announced a new CFO and posted year-end losses, while analysts have …
Matthew W. Vittitow, Chief Operating Officer of GrabAGun Digital Holdings Inc (PEW), sold 2,043 shares on April 16, 2026 for $2.98 per share to satisfy tax-withholding obligations tied to vested restricted stock units. The sale, executed under an established Rule 10b5-1 plan, reduced his direct holdings to 2,517,945 shares. The transaction comes as…
Klaviyo Co-CEO Andrew Bialecki sold 200,000 shares of Series A common stock on April 14, 2026, realizing roughly $3.4 million. The transactions, executed under a pre-arranged Rule 10b5-1 plan, coincided with a one-for-one conversion of those Class A shares into Series B shares. The company's stock has rebounded from its 52-week low but remains down…
A ten percent owner of Rocky Mountain Chocolate Factory, Inc. executed an indirect sale of 54,100 shares between February 19 and March 5, 2026, yielding roughly $140,833. The disposing party, American Heritage Railways, Inc., still beneficially holds 945,900 shares. The transactions come amid a period of strong share-price performance and as the co…
